Navigation Links
Long-term neuropsychological impairment is common in acute lung injury survivors
Date:4/5/2012

Cognitive and psychiatric impairments are common among long-term survivors of acute lung injury (ALI), and these impairments can be assessed using a telephone-based test battery, according to a new study.

"Neuropsychological impairment is increasingly being recognized as an important outcome among survivors of critical illness, but neuropsychological function in long-term ALI survivors has not been assessed in a multi-center trial, and evidence on the etiology of these impairments in ALI survivors is limited," said lead author Mark E. Mikkelsen, MD, MSCE, assistant professor of medicine at the University of Pennsylvania. "To overcome the constraints of in-person assessment, we developed a telephone battery of standardized neuropsychological tests that could be administered by a non-expert and used it to assess a subset of 122 ALI survivors from the Acute Respiratory Distress Syndrome Clinical Trials Network Fluid and Catheter Treatment Trial."

"We found that neuropsychological function can be assessed by telephone in a multi-center trial, and that long-term neuropsychological impairment is common in these patients," continued Dr. Mikkelsen. "We also found that hypoxemia was associated with an increased risk for long-term cognitive and psychiatric impairment."

The findings were published online ahead of print publication in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

The test battery was administered to study subjects at two and 12 months after discharge from the hospital. At 12 months, memory, verbal fluency, and executive function (a set of cognitive abilities necessary for effective daily functioning) were impaired in 13, 16, and 49 percent of survivors, respectively, while cognitive impairment (defined as impairment in memory, verbal fluency, and/or executive function) was found in 41 of 75 survivors (55 percent). Depression, post-traumatic stress disorder, and anxiety were found in 36, 39, and 62 percent of long-term survivors.

Enrollment in a conservative fluid-management strategy was significantly associated with the development of cognitive impairment, and lower partial pressure of arterial oxygen during the trial was associated with a significantly increased risk of both cognitive and psychiatric impairment. "Although it is plausible that use of a conservative fluid-management strategy was associated with an increased risk for long-term cognitive impairment," Dr. Mikkelsen said, "based on the small sample size and an unclear mechanism, this finding warrants confirmation."

The study had a few limitations, including its small sample size and the use of self-report for several measures.

"Our study confirms earlier research showing that cognitive and psychiatric morbidity are common among long-term survivors of ALI," concluded Dr. Mikkelsen. "We are indebted to the NIH for supporting EA-PAC, the parent study of the present study, and for recognizing the importance of assessing a multitude of long-term outcomes to properly understand survivorship and ultimately to improve the lives of critically ill survivors."


'/>"/>

Contact: Nathaniel Dunford
ndunford@thoracic.org
212-315-8620
American Thoracic Society
Source:Eurekalert

Related medicine news :

1. Vaccine yielded encouraging long-term survival rates in certain patients with NSCLC
2. Long-Term Estrogen Therapy Does Up Breast Cancer Risk: Study
3. U.S. Underestimates Long-Term Costs of Obesity, Experts Say
4. Groundbreaking, long-term study of head injuries among athletes kicks off with NCAA grant
5. HIV/AIDS vaccine shows long-term protection against multiple exposures in non-human primates
6. First study on long-term cognitive effects of breast cancer chemotherapy finds subtle impairment among women who received CMF regimen
7. Study finds some insulin production in long-term Type 1 diabetes
8. People who retire early due to back problems face long-term financial disadvantage
9. Radiation plus chemotherapy provides long-term positive results for head and neck cancer patients
10. Oxford University Press and Medical Council on Alcohol announce long-term partnership
11. Severe Brain Injury When Young May Have Long-Term Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2017)... ... 2017 , ... CareSet Labs released the Root NPI Graph today at the ... greatly improved version of the Doctor Referral teaming dataset commonly available from Medicare. , ... called the the “Doctor Referral Dataset” as released by Medicare and “DocGraph” as released ...
(Date:6/24/2017)... ... June 24, 2017 , ... ... at 217 Portion Road in Lake Ronkonkoma, Dental365 offers patients high-quality and affordable ... that visits to the dentist fit into their patients’ busy lifestyles. Dental365 also ...
(Date:6/23/2017)... CA (PRWEB) , ... June 23, 2017 , ... By ... earned its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ... the top 1% of all charities reviewed by Charity Navigator and earns ANRF a ...
(Date:6/23/2017)... ... June 23, 2017 , ... Military Connection friend ... entry to the JFK Virgin Atlantic lounge. , Bensko is no stranger to ... years ago, Bensko dedicated her life to supporting our wounded veterans. A world-class photographer, ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... June 14, 2017 The Bio Supply Management ... City of Fremont and the Biomedical Manufacturing ... industry in California by providing ... networking, and fostering workforce development. The primary focus of ... of start-ups, as well as small and mid-sized biomedical ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: